文献速递药物不良反应与药物警戒

通过移动应用VigiBIP®收到的药物不良反应报告:与传统报告方法的比较

Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting.
PubMed 文献 · Drug Saf · 2018-01-01

共收到4102份报告,其中4.7%通过VigiBIP®提交。VigiBIP®的患者报告比例显著更高(6.7% vs 3.4%,p=0.01),且报告的不良反应和涉及药物因报告方法而异。

要点

  • VigiBIP®移动应用是药物警戒的补充工具,患者报告比例显著高于传统方法
  • 通过VigiBIP®报告的不良反应类型和涉及药物与传统方法存在差异
  • 移动应用报告仅占全部报告的4.7%,但有助于提高患者参与度

核心结论

  • 移动应用是药物警戒的补充工具,VigiBIP®的报告者类型和不良反应类型与传统方法不同。

主要发现

  • 共收到4102份报告,其中4.7%通过VigiBIP®提交。
  • VigiBIP®的患者报告比例显著高于传统方法(6.7% vs 3.4%,p=0.01)。
  • 报告的不良反应和涉及药物因报告方法不同而存在差异。

临床怎么用

  • 临床药师可将移动应用作为药物警戒的补充报告渠道,尤其有助于提高患者主动报告不良反应的参与度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The use of mobile apps is increasing in medicine. In pharmacovigilance, mobile apps may help to increase adverse drug reaction reporting and improve the communication of safety issues. The Toulouse University Pharmacovigilance Center has developed VigiBIP®, a free smartphone app available on Android and Apple stores, for reporting adverse drug reactions and requesting drug safety information. OBJECTIVE: The present study was performed to compare the main characteristics of spontaneous adverse drug reaction reports received through VigiBIP® with classical methods of reporting (phone, e-mail, fax, letter, website) during 25 months (2015-17). METHODS: Using the Chi squared test, we compared the type of reporter, adverse drug reaction seriousness, drugs involved and reported ADRs using VigiBIP® and classical methods of reporting RESULTS: A total of 4102 reports were received by the Toulouse University Pharmacovigilance Center, including 4.7% through VigiBip®. Patients' reports were significantly more frequent with VigiBip® (6.7%) than with classical methods (3.4%) [p = 0.01]. Reported adverse drug reactions and involved drugs differed according to the method of reporting used. CONCLUSION: Our study shows that a mobile app is an additional tool used in pharmacovigilance. Types of reporters and adverse drug reactions in VigiBIP were different to those seen in classical methods of reporting.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Montastruc F, Bagheri H, Lacroix I, et al. Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting. Drug Saf. 2018. PMID: 29270770. doi:10.1007/s40264-017-0630-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。